<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044889"><TermName>BMS-214662</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>BMS-214662</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de inhibidor de la farnesiltransferasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2003-10-15</DateLastModified></GlossaryTerm>
